Adenosine A_2A receptor antagonists are potential antidepressants : evidence based on pharmacology and A_2A receptor knockout miceEL YACOUBI, Malika; LEDENT, Catherine; PARMENTIER, Marc et al.British journal of pharmacology. 2001, Vol 134, Num 1, pp 68-77, issn 0007-1188Article

Study of Istradefylline in Patients with Parkinson's Disease on Levodopa with Motor FluctuationsHAUSER, Robert A; SHULMAN, Lisa M; TRUGMAN, Joel M et al.Movement disorders. 2008, Vol 23, Num 15, pp 2177-2185, issn 0885-3185, 9 p.Article

Inhibition of monoamine oxidase B by selective adenosine A_2Areceptor antagonistsPETZER, Jacobus P; STEYN, Salome; CASTAGNOLI, Kay P et al.Bioorganic & medicinal chemistry. 2003, Vol 11, Num 7, pp 1299-1310, issn 0968-0896, 12 p.Article

Actions of adenosine A_2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTPSHIOZAKI, Shizuo; ICHIKAWA, Shunji; NAKAMURA, Joji et al.Psychopharmacologia. 1999, Vol 147, Num 1, pp 90-95, issn 0033-3158Article

Adenosine A_2A antagonist : A novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeysKANDA, T; JACKSON, M. J; SMITH, L. A et al.Annals of neurology. 1998, Vol 43, Num 4, pp 507-513, issn 0364-5134Article

Dual actions of A_2A adenosine receptor antagonists on motor dysfunction and neurodegenerative processesONGINI, Ennio; MONOPOLI, Angela; IMPAGNATIELLO, Francesco et al.Drug development research. 2001, Vol 52, Num 1-2, pp 379-386, issn 0272-4391Conference Paper

Combined use of the adenosine A_2A antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeysKANDA, T; JACKSON, M. J; SMITH, L. A et al.Experimental neurology (Print). 2000, Vol 162, Num 2, pp 321-327, issn 0014-4886Article

Cellular and behavioural effects of the adenosine A_2a receptor antagonist KW-6002 in a rat model of L-DOPA-induced dyskinesiaLUNDBLAD, M; VAUDANO, E; CENCI, M. A et al.Journal of neurochemistry. 2003, Vol 84, Num 6, pp 1398-1410, issn 0022-3042, 13 p.Article

A_2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's diseaseBIBBIANI, F; OH, J. D; PETZER, J. P et al.Experimental neurology (Print). 2003, Vol 184, Num 1, pp 285-294, issn 0014-4886, 10 p.Article